Literature DB >> 26992453

Mesenchymal stem cells: From stem cells to sarcomas.

Kwan Liang Lye1, Norshariza Nordin1,2, Sharmili Vidyadaran2,3, Karuppiah Thilakavathy1,2.   

Abstract

Mesenchymal stem cells (MSCs) have garnered vast interests in clinical settings, especially in regenerative medicine due to their unique properties-they are reliably isolated and expanded from various tissue sources; they are able to differentiate into mesodermal tissues such as bones, cartilages, adipose tissues, and muscles; and they have unique immunosuppressive properties. However, there are some concerns pertaining to the role of MSCs in the human body. On one hand, they are crucial component in the regeneration and repair of the human body. On the contrary, they are shown to transform into sarcomas. Although the exact mechanisms are still unknown, many new leads have pointed to the belief that MSCs do play a role in sarcomagenesis. This review focuses on the current updates and findings of the role of MSCs in their transformation process into sarcomas.
© 2016 International Federation for Cell Biology.

Entities:  

Keywords:  mesenchymal stem cell; oncogene; regenerative medicine; sarcoma; spontaneous transformation

Mesh:

Year:  2016        PMID: 26992453     DOI: 10.1002/cbin.10603

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  19 in total

1.  Photopolymerizable Hydrogel-Encapsulated Fibromodulin-Reprogrammed Cells for Muscle Regeneration.

Authors:  Pu Yang; Chenshuang Li; Min Lee; Anna Marzvanyan; Zhihe Zhao; Kang Ting; Chia Soo; Zhong Zheng
Journal:  Tissue Eng Part A       Date:  2020-06-02       Impact factor: 3.845

Review 2.  YAP and the Hippo pathway in pediatric cancer.

Authors:  Atif A Ahmed; Abdalla D Mohamed; Melissa Gener; Weijie Li; Eugenio Taboada
Journal:  Mol Cell Oncol       Date:  2017-02-25

3.  Mesenchymal Stem Cells: Miraculous Healers or Dormant Killers?

Authors:  Abbas Ghaderi; Shabnam Abtahi
Journal:  Stem Cell Rev Rep       Date:  2018-10       Impact factor: 5.739

Review 4.  TP53 in bone and soft tissue sarcomas.

Authors:  Elizabeth Thoenen; Amanda Curl; Tomoo Iwakuma
Journal:  Pharmacol Ther       Date:  2019-07-02       Impact factor: 12.310

5.  CDKN2B upregulation prevents teratoma formation in multipotent fibromodulin-reprogrammed cells.

Authors:  Zhong Zheng; Chenshuang Li; Pin Ha; Grace X Chang; Pu Yang; Xinli Zhang; Jong Kil Kim; Wenlu Jiang; Xiaoxiao Pang; Emily A Berthiaume; Zane Mills; Christos S Haveles; Eric Chen; Kang Ting; Chia Soo
Journal:  J Clin Invest       Date:  2019-07-15       Impact factor: 14.808

6.  MRI detection of the malignant transformation of stem cells through reporter gene expression driven by a tumor-specific promoter.

Authors:  Jun Sun; Jie Huang; Guangcheng Bao; Helin Zheng; Cui Wang; Jie Wei; Yuanqiao Fu; Jiawen Qiu; Yifan Liao; Jinhua Cai
Journal:  Stem Cell Res Ther       Date:  2021-05-12       Impact factor: 6.832

7.  Challenges of bone tissue engineering in orthopaedic patients.

Authors:  Enrique Guerado; Enrique Caso
Journal:  World J Orthop       Date:  2017-02-18

Review 8.  Metabolic landscapes in sarcomas.

Authors:  Richard Miallot; Franck Galland; Virginie Millet; Jean-Yves Blay; Philippe Naquet
Journal:  J Hematol Oncol       Date:  2021-07-22       Impact factor: 17.388

Review 9.  Managing sarcoma: where have we come from and where are we going?

Authors:  Jenna S Bleloch; Reyna D Ballim; Serah Kimani; Jeannette Parkes; Eugenio Panieri; Tarryn Willmer; Sharon Prince
Journal:  Ther Adv Med Oncol       Date:  2017-09-20       Impact factor: 8.168

Review 10.  Molecular mechanisms underpinning sarcomas and implications for current and future therapy.

Authors:  Victoria Damerell; Michael S Pepper; Sharon Prince
Journal:  Signal Transduct Target Ther       Date:  2021-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.